Results - Announcements
Hikal Ltd share price inched up 4.60% to Rs 220.65 after the company's net profit contracted by 17.57% to Rs 6.1 crore, while revenue from operations improved marginally 7.83% to Rs 431.1 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.72 lakh crore, rising 5.09%. It has improved by 2.16% over last one week and moved up slightly by 0.86% in last one month while the market capitalization of Hikal Ltd has marginally improved by 9.07% and 4.95% in the same period respectively.
Profit before tax (PBT) of Hikal Ltd stood at Rs 8.5 crore in Q3 FY26, crashing by 81.91% year-on-year, and falling 14.14% quarter-on-quarter. EBITDA came in at Rs 43 crore, surging by 715.09% YoY and expanding by 22.73% sequentially.
Total expenses grew marginally by 5.51% to Rs 431.0 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 236.8 crore, witnessing a sharp rise of 22.06% YoY, while employee benefits expense was at Rs 63.8 crore, tanking by 14.25% YoY.
For the TTM ended FY26, revenue from operations softened by 8.04% to Rs 1695.2 crore, while net profit plunged by 153.74% to Rs 48.8 crore, compared to previous TTM. EBITDA surged by 35180% to Rs 208.1 crore, and PBT collapsed by 163.25% to Rs 78.3 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 302.0 crore in FY26, as against Rs 280.4 crore in FY25.
Hikal Ltd nosedived by 9.77% in last one year, performing in line with the benchmark BSE Sensex which has eased by 9.87% during the same period.